New portfolio structure introduces four specialised categories spanning sports medicine, joint preservation, reconstruction and technology-led orthopedic care
Bangalore, 26 th October 2026: Healthium Medtech Limited, a global medical devices company, today
announced the strategic rebranding of its dedicated arthroscopy business from SIRONIX Arthroscopy to
‘SIRONIX Orthopedics’, marking the next phase in its growth and expansion across the extended
orthopedic landscape. The new identity reflects SIRONIX’s ambition to address a wider range of specialty
orthopedic care while building on its established expertise in arthroscopy and sports medicine.
Since its inception, SIRONIX has enabled surgeons with innovative arthroscopy solutions and established
a strong presence in sports medicine through its surgeon partnerships and solutions. It was the first
Indian company to receive EU-MDR certification for an arthroscopy portfolio, a milestone that
underscores its regulatory and product development capabilities. SIRONIX also holds US FDA 510(k)
clearances, alongside 80+ patents across India and the USA.
The global orthopedic device market is experiencing strong growth and is projected to reach USD 68
billion by 2030 1 . With this momentum, the rebranding of SIRONIX reflects the strategic vision to
strengthen its market presence and capitalize on emerging growth opportunities.
Building on this foundation, SIRONIX Orthopedics will support surgeons across the full continuum of
orthopedic care, from preserving joints to restoring them, and from advanced implants to intelligent
surgical technologies. The new portfolio structure will bring greater focus to its offerings while enabling
SIRONIX Orthopedics to address a wider range of orthopedic needs.
Under the new identity, the portfolio will introduce four new strategic product categories:
- SIRONIX SPORTSMED – continuing its leadership on sports medicine.
- SIRONIX REGEN – focusing on solutions supporting tissue regeneration and joint preservation.
- SIRONIX RECON – addressing joint reconstruction and restoration of mobility.
- SIRONIX TECH – bringing technology-led solutions focused on surgical planning, navigation and
advanced surgical capabilities.
Commenting on the repositioning, Gaurav Goel, Chief Executive Officer and Managing Director,
Healthium Medtech Limited, said, “SIRONIX has built a strong foundation in arthroscopy and sports
medicine, establishing a meaningful presence in the orthopedic space. As the market evolves, we see an
opportunity to build on this foundation and participate more meaningfully across the broader orthopedic
landscape. The transition to SIRONIX Orthopedics reflects that ambition and marks an important step in
the evolution of the business. It positions us to pursue new opportunities, strengthen our presence across
orthopedics and build a business that is equipped for the next phase of growth.”
Anoop Penupolu, Global SBU Head – SIRONIX, said, “SIRONIX has grown significantly from its roots in
arthroscopy and sports medicine, and this next phase is about giving that growth a clearer structure.
SIRONIX Orthopedics brings together four specialised pillars, each with a distinct role across orthopedic
care, from sports medicine and joint preservation to reconstruction and technology-enabled surgery. This
structure will allow us to build greater depth within each area while creating a more connected portfolio.
As we embark on this new chapter, our focus will be on strengthening each category and building
SIRONIX Orthopedics into a portfolio that reflects the changing needs of modern orthopedic practice.”
As orthopedic care continues to evolve, SIRONIX Orthopedics will continue to invest in strengthening its
expertise and developing solutions that can contribute to better surgical outcomes and patient recovery.
About Healthium Medtech Limited:
Healthium Medtech Limited is a global medtech company focused on products in surgical, post-surgical,
advanced wound care, arthroscopy and infection prevention segments. 1 in 5 surgeries conducted
globally uses a Healthium product. It is the largest non-captive manufacturer of surgical needles globally.
With a vision to provide access to precision medtech for every patient globally, the company has built the
nation’s largest sales force with an extensive market access in India, covering over 40,000 surgeons
across 18,000 hospitals. The company’s diverse portfolio includes 52,000 SKUs across advanced
surgery, arthroscopy, wound care and infection prevention products. With a strong focus on R&D, the
company has 7 high precision, integrated and scaled manufacturing facilities with global certifications and
approvals like US FDA, CDSCO, TGA, ISO, cGMP and CE under EUDMR norms. Healthium has
established a significant global presence, with exports spanning over 100 countries, including key
markets such as the USA, France, Germany, and Brazil. The company also has a strong innovation
footprint, with more than 100 designs and patents across the US, Europe, and India. Over the last four
years, Healthium has expanded its portfolio through the launch of 35+ new products, including a patented
range of arthroscopy solutions.
Media Contact:
Priya Kumar
Head- Corporate Communications
Healthium Medtech Limited
Priya.Kumar@healthiummedtech.com
